Gene · 8564
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cross-cultural adaptation of the Job Insecurity Scale (JIS) in Brazil and cross-national analysis of Job Insecurity effects in Brazil and Spain. | BMC Psychol | 2023 | 37060104 | PubTator, text mining | PubMed |
| Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk. | Nutrients | 2023 | 37049606 | PubTator, text mining | PubMed |
| Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder. | Cells | 2023 | 37048160 | PubTator, text mining | PubMed |
| Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials. | Br J Cancer | 2023 | 37041200 | PubTator, text mining | PubMed |
| Development and validation of a short nutrition literacy scale for young adults. | Front Nutr | 2023 | 37020809 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| From "doing alone" to "working together"-Research on the influence of spiritual leadership on employee morale. | Front Psychol | 2023 | 37008872 | PubTator, text mining | PubMed |
| A convolutional neural network based online teaching method using edge-cloud computing platform. | J Cloud Comput (Heidelb) | 2023 | 37007982 | PubTator, text mining | PubMed |
| The metabolites of de novo NAD+ synthesis are a valuable predictor of acute kidney injury. | Clin Kidney J | 2023 | 37007695 | PubTator, text mining | PubMed |
| A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. | Front Immunol | 2023 | 37006314 | PubTator, text mining | PubMed |
| [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism]. | Nihon Yakurigaku Zasshi | 2023 | 36990795 | PubTator, text mining | PubMed |
| Markers of arterial stiffness and urinary metabolomics in young adults with early cardiovascular risk: the African-PREDICT study. | Metabolomics | 2023 | 36988718 | PubTator, text mining | PubMed |
| Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA). | Pharmaceuticals (Basel) | 2023 | 36986469 | PubTator, text mining | PubMed |
| Altered Tryptophan-Kynurenine Pathway in Delirium: A Review of the Current Literature. | Int J Mol Sci | 2023 | 36982655 | PubTator, text mining | PubMed |
| IFN-Inducible SerpinA5 Triggers Antiviral Immunity by Regulating STAT1 Phosphorylation and Nuclear Translocation. | Int J Mol Sci | 2023 | 36982532 | PubTator, text mining | PubMed |
| The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis. | Biomedicines | 2023 | 36979924 | PubTator, text mining | PubMed |
| The role of microfinance institutions on women's entrepreneurship development. | J Innov Entrep | 2023 | 36968150 | PubTator, text mining | PubMed |
| Modulating the Kynurenine pathway or sequestering toxic 3-hydroxykynurenine protects the retina from light-induced damage in Drosophila. | PLoS Genet | 2023 | 36952572 | PubTator, text mining | PubMed |
| Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases. | Eur J Med Chem | 2023 | 36917881 | PubTator, text mining | PubMed |
| Intensity of Depression Symptoms Is Negatively Associated with Catalase Activity in Master Athletes. | Int J Environ Res Public Health | 2023 | 36901407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8564/papers?page=14